Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare Stokes

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Neuropharmacology|July 24, 2010
Cysteine accessibility analysis of the human alpha7 nicotinic acetylcholine receptor ligand-binding domain identifies L119 as a gatekeeperRoger L Papke, Clare Stokes, Dustin K Williams, et al.
Biochemical Pharmacology|January 29, 2013
Point-to-point ligand-receptor interactions across the subunit interface modulate the induction and stabilization of conformational states of alpha7 nAChR by benzylidene anabaseinesMatthew D Isaacson, Nicole A Horenstein, Clare Stokes, et al.
Plos Pathogens|November 24, 2025
The citrus tristeza virus p33 protein functions as a viroporinVicken Aknadibossian, Clare Stokes, Roger L Papke, et al.
Neuropharmacology|September 27, 2023
Pharmacological profiles and anti-inflammatory activity of pCN-diEPP and mCN-diEPP, new alpha9alpha10 nicotinic receptor ligandsKatrin Richter, Sara M Herz, Clare Stokes, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 24, 2022
Differential Activation and Desensitization States Promoted by Noncanonical <i>α</i>7 Nicotinic Acetylcholine Receptor AgonistsClare Stokes, Gisela Andrea Camacho-Hernandez, Ganesh A Thakur, et al.
European Journal of Pharmacology|May 18, 2021
Stable desensitization of α<sub>7</sub> nicotinic acetylcholine receptors by NS6740 requires interaction with S36 in the orthosteric agonist binding siteMaria Chiara Pismataro, Nicole A Horenstein, Clare Stokes, et al.
Scientific Reports|October 11, 2017
Rabies virus modifies host behaviour through a snake-toxin like region of its glycoprotein that inhibits neurotransmitter receptors in the CNSKarsten Hueffer, Shailesh Khatri, Shane Rideout, et al.
Molecular Pharmacology|October 6, 2020
Allosterically Potentiated <i>α</i>7 Nicotinic Acetylcholine Receptors: Reduced Calcium Permeability and Current-Independent Control of Intracellular CalciumDouglas R Miller, Habibeh Khoshbouei, Sumanta Garai, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2018
The Antinociceptive and Anti-Inflammatory Properties of the <i>α</i>7 nAChR Weak Partial Agonist <i>p</i>-CF<sub>3</sub> <i>N</i>,<i>N</i>-diethyl-<i>N</i>'-phenylpiperazineMarta Quadri, Deniz Bagdas, Wisam Toma, et al.
Molecular Pharmacology|October 24, 2018
Macroscopic and Microscopic Activation of <i>α</i>7 Nicotinic Acetylcholine Receptors by the Structurally Unrelated Allosteric Agonist-Positive Allosteric Modulators (ago-PAMs) B-973B and GAT107Marta Quadri, Sumanta Garai, Ganesh A Thakur, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Neuropharmacology|July 24, 2010
Cysteine accessibility analysis of the human alpha7 nicotinic acetylcholine receptor ligand-binding domain identifies L119 as a gatekeeperRoger L Papke, Clare Stokes, Dustin K Williams, et al.
Biochemical Pharmacology|January 29, 2013
Point-to-point ligand-receptor interactions across the subunit interface modulate the induction and stabilization of conformational states of alpha7 nAChR by benzylidene anabaseinesMatthew D Isaacson, Nicole A Horenstein, Clare Stokes, et al.
Plos Pathogens|November 24, 2025
The citrus tristeza virus p33 protein functions as a viroporinVicken Aknadibossian, Clare Stokes, Roger L Papke, et al.
Neuropharmacology|September 27, 2023
Pharmacological profiles and anti-inflammatory activity of pCN-diEPP and mCN-diEPP, new alpha9alpha10 nicotinic receptor ligandsKatrin Richter, Sara M Herz, Clare Stokes, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 24, 2022
Differential Activation and Desensitization States Promoted by Noncanonical <i>α</i>7 Nicotinic Acetylcholine Receptor AgonistsClare Stokes, Gisela Andrea Camacho-Hernandez, Ganesh A Thakur, et al.
European Journal of Pharmacology|May 18, 2021
Stable desensitization of α<sub>7</sub> nicotinic acetylcholine receptors by NS6740 requires interaction with S36 in the orthosteric agonist binding siteMaria Chiara Pismataro, Nicole A Horenstein, Clare Stokes, et al.
Scientific Reports|October 11, 2017
Rabies virus modifies host behaviour through a snake-toxin like region of its glycoprotein that inhibits neurotransmitter receptors in the CNSKarsten Hueffer, Shailesh Khatri, Shane Rideout, et al.
Molecular Pharmacology|October 6, 2020
Allosterically Potentiated <i>α</i>7 Nicotinic Acetylcholine Receptors: Reduced Calcium Permeability and Current-Independent Control of Intracellular CalciumDouglas R Miller, Habibeh Khoshbouei, Sumanta Garai, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2018
The Antinociceptive and Anti-Inflammatory Properties of the <i>α</i>7 nAChR Weak Partial Agonist <i>p</i>-CF<sub>3</sub> <i>N</i>,<i>N</i>-diethyl-<i>N</i>'-phenylpiperazineMarta Quadri, Deniz Bagdas, Wisam Toma, et al.
Molecular Pharmacology|October 24, 2018
Macroscopic and Microscopic Activation of <i>α</i>7 Nicotinic Acetylcholine Receptors by the Structurally Unrelated Allosteric Agonist-Positive Allosteric Modulators (ago-PAMs) B-973B and GAT107Marta Quadri, Sumanta Garai, Ganesh A Thakur, et al.
Pageof 6